Encouraging genomic testing is critical to identifying lung cancer patients who would benefit from targeted therapy
Stephen Hamilton, MD, July 27, 22Read More
As we reach the endemic phase of COVID-19, there are certain health and financial impacts we expect to see over the next 2 to 5 years.
Christine Gilroy, MD, MSPH, May 27, 22Read More
Oncology treatments get more complex every day. Pairing subspecialists with community oncologists improves patient access to the best possible treatments while keeping their care close to home.
Stephen Hamilton, MD, May 23, 22Read More
Despite a decline in overall cancer deaths attributed to a decrease in smoking, trends indicate a potential new surge.
Bhuvana Sagar, MD, MBA, May 17, 22Read More